Search
Verona Pharma Shares Surge Over 20% in U.S. Pre-market Trading
3 week ago /
Read about 0 minute
Author：小编
Merck & Co. has agreed to acquire Verona Pharma for $107 per share, amounting to a total transaction value of approximately $10 billion. This offer signifies a significant 23% premium over Verona Pharma's closing price on Tuesday.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
